CNSY
CERENOME, INC.Company Information
- Company Name
- CERENOME, INC.
- CIK
- CIK0001095981
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CNSY: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- CNSY
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-04
- Last sale
- 2023-11-20
- Shares purchased (TTM)
- 130,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 603,184
- Shares outstanding
- 6,898,804
- Ownership
- 8.74%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -25.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 3 | 4 | 13 | 2 | 10 | 0 | 1 | 5 | 3 | 9 | 11 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | - | - | 5 | - | - | - | - | - | - | - | - | - | ||||||
| Short Term Investments | 6 | 12 | 4 | 3 | 5 | - | 4 | 4 | 4 | 0 | - | - | ||||||
| Grants Receivable Current | 2 | 1 | 0 | - | 1 | - | 1 | - | - | - | - | 0 | ||||||
| Other Assets Current | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Assets Current | 12 | 18 | 15 | 18 | 9 | 11 | 5 | 5 | 9 | 4 | 10 | 12 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 14 | 20 | 16 | 19 | 10 | 12 | 7 | 7 | 11 | 6 | 11 | 13 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 8 | 6 | 6 | 12 | 6 | 9 | 11 | 8 | 7 | 6 | 7 | 6 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Current | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 0 | - | - | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | - | 4 | 4 | 4 | ||||||
| Lines Of Credit Current | 0 | 1 | 1 | - | - | - | 3 | 3 | 3 | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 9 | 8 | 12 | 14 | 7 | 11 | 16 | 12 | 19 | 10 | 11 | 11 | ||||||
| Operating Lease Liability Noncurrent | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Noncurrent | - | - | - | - | - | - | - | - | - | - | 2 | - | ||||||
| Liabilities | 9 | 8 | 12 | 14 | 7 | 36 | 16 | 12 | 19 | 10 | 13 | 11 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -0 | - | ||||||
| Additional Paid In Capital | 538 | 535 | 520 | 516 | 509 | 488 | 485 | 485 | 480 | 479 | 479 | 479 | ||||||
| Retained Earnings Accumulated Deficit | -532 | -523 | -516 | -510 | -506 | -511 | -493 | -490 | -487 | -484 | -481 | -477 | ||||||
| Stockholders Equity | 5 | 12 | 4 | 5 | 3 | -24 | -9 | -5 | -8 | -5 | -1 | 3 | ||||||
| Liabilities And Stockholders Equity | 14 | 20 | 16 | 19 | 10 | 12 | 7 | 7 | 11 | 6 | 11 | 13 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 7 | 7 | 6 | 5 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 7 | 7 | 6 | 5 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCERENOME, INC. (CNSY) — SEC Financial Statements & Analysis
CERENOME, INC. (CNSY) is a surgical & medical instruments & apparatus company, incorporated in DE. CERENOME, INC. trades on Nasdaq as: CNSY. CERENOME, INC. (CNSY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, CERENOME, INC. carries a market cap of $30.15M, a P/E ratio of -1.16x, a P/B ratio of 5.52x, a P/S ratio of 7.17x, an enterprise value of $27.78M, and an EV/EBITDA multiple of -1.07x. On profitability, it posts a gross margin of 103.81%, an operating margin of -628.12%, a net margin of -620.70%, a Return on Equity (ROE) of -614.05%, a Return on Assets (ROA) of -214.01%, and a Return on Invested Capital (ROIC) of -1291.46%. Per share, it reports EPS of $-3.78, diluted EPS of $-3.78, free cash flow per share of $-3.41, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -20.95% year-over-year, net income growth of 37.11% year-over-year, and EPS growth of -61.53% year-over-year. On the balance sheet, it maintains a current ratio of 1.37x, a quick ratio of 1.37x, working capital of $3.20M, a debt-to-equity ratio of 1.57x, a debt ratio of 0.61, an interest coverage ratio of -46.32x, free cash flow of $-23.55M (TTM), and net debt of $-2.37M. Figures sourced from SEC EDGAR.
- Market Cap
- $30.15M
- P/E TTM
- -1.16x
- EPS TTM
- $-3.78
- P/B TTM
- 5.52x
- ROE TTM
- -614.05%
- ROA TTM
- -214.01%
- Debt To Equity
- 1.57x
- Free Cash Flow TTM
- $-23.55M
- Net Revenue TTM Growth 1Y
- -20.95%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CERENOME, INC. in?
CERENOME, INC. (CNSY) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does CNSY trade on?
CERENOME, INC. (CNSY) trades on the Nasdaq.
Where is CERENOME, INC. incorporated?
CERENOME, INC. is incorporated in DE.
When was CERENOME, INC. (CNSY)'s most recent SEC filing?
CERENOME, INC. (CNSY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is CNSY's market cap?
CERENOME, INC. (CNSY) has a market capitalization of $30.15M as of 2026-06-30.
What is CNSY's EPS (earnings per share)?
CERENOME, INC. (CNSY)'s trailing twelve month EPS is $-3.78 as of 2026-06-30.
What is CNSY's ROE (return on equity)?
CERENOME, INC. (CNSY)'s trailing twelve month Return on Equity (ROE) is -614.05% as of 2026-06-30.
What is CNSY's ROA (return on assets)?
CERENOME, INC. (CNSY)'s trailing twelve month Return on Assets (ROA) is -214.01% as of 2026-06-30.
What is CNSY's ROIC (return on invested capital)?
CERENOME, INC. (CNSY)'s trailing twelve month Return on Invested Capital (ROIC) is -1291.46% as of 2026-06-30.
What is CNSY's EV/EBITDA?
CERENOME, INC. (CNSY)'s trailing twelve month EV/EBITDA is -1.07x as of 2026-06-30.